相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome
Ilias Katsikis et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2011)
The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia
Dimitrios Panidis et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
Serum Anti-Mullerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
Dimitrios Panidis et al.
MEDICAL HYPOTHESES (2011)
Association of ghrelin and leptin with reproductive hormones in constitutional delay of growth and puberty
Mervat M. El-Eshmawy et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
Athanasia Piouka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels
Dimitrios Panidis et al.
FERTILITY AND STERILITY (2008)
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
David B. Seifer et al.
FERTILITY AND STERILITY (2007)
Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries
Laura Pellatt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Association of anti-mullerian hormone levels with obesity in late reproductive-age women
Ellen W. Freeman et al.
FERTILITY AND STERILITY (2007)
Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid
C Feinle-Bisset et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Serum mullerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
Y Siow et al.
FERTILITY AND STERILITY (2005)
Medical progress: Polycystic ovary syndrome
DA Ehrmann
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
R Fleming et al.
FERTILITY AND STERILITY (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome
LJ Moran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
分享论文
